Demographic considerations in tacrolimus pharmacokinetics.
Fitzsimmons
W E
WE
Deerfield, Illinois, USA.
Bekersky
I
I
Dressler
D
D
Raye
K
K
Hodosh
E
E
Mekki
Q
Q
D000328:Adult; D044383:Black People; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000502:physiology; D018592:Cross-Over Studies; D003710:Demography; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D012727:Sex Characteristics; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D044465:White People
D007166:Immunosuppressive Agents; D016559:Tacrolimus